The early bird gets the worm: Benefits and future directions with early antiretroviral therapy initiation in primary HIV infection

13Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Primary HIV infection is defined as the first few weeks after infection where plasma viremia is rapidly increasing. Early diagnosis of primary HIV infection enhances the tendency of behavioral changes in newly infected individuals to prevent secondary HIV transmission. Early antiretroviral therapy (ART) benefits individuals by reducing plasma viral load, gut damage, microbial translocation and subsequent systemic immune activation. Early ART leads to the establishment of low HIV reservoir size that may contribute to HIV eradication research. However, substantial diagnostic and logistical barriers remain as a burden to rapid diagnosis and early treatment initiation. In this review, we critically evaluate the effects of early ART and summarize hurdles that must be addressed to implement rapid treatment initiation for newly infected individuals.

Cite

CITATION STYLE

APA

Chen, J., Ramendra, R., Lu, H., & Routy, J. P. (2018). The early bird gets the worm: Benefits and future directions with early antiretroviral therapy initiation in primary HIV infection. Future Virology, 13(11), 779–786. https://doi.org/10.2217/fvl-2018-0110

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free